Moreover, compared to these latter tests, the APAC score obtained greater diagnostic value for the identification of patients with (very) early (BCLC 0/A) stage HCC, HCC patients with low AFP values, and those within Milan criteria, therefore suggesting its potential superior performance for surveillance of high-risk individuals. This evidence concerns the gene AFP and hepatocellular carcinoma.